Neos Therapeutics provided earning guidance for the first quarter and full year 2019. For the first quarter of 2019, The company expects net revenue per pack to increase as the begins to move beyond the annual or early year high deductible period and the impact of new commercial strategy becomes evident in the data. For the full year 2019, the company expects net revenue numbers to throughout the year.